About Chantix

Chantix is a name to reckon with in the quit smoking drug category in a rather short period of time. After Zyban was introduced some ten years ago as an anti smoking drug, no drugs have been approved so far, till Chantix hit the headlines. Chantix has been introduced at a perfectly right time, when the figures and statistics of nicotine (smoking) related deaths as per the WHO reports have alarmed the medical world.

Chantix (Varenicline) is a trademark drug of Pfizer Inc. that just got the approval of the FDA on May 11, 2006 as a treatment for anti smoking in adults. Chantix is a quit smoking drug with a potential far greater than the other drugs in its category in relieving smokers from the unhealthy vice of smoking. With an approach different from other drugs in the quit smoking category, Chantix would help you to gradually give up smoking without going through any of those nerve-wrecking withdrawal symptoms. Chantix treatment is very effective if you make an educated approach.

Chantix has Varenicline (as the tartrate salt) as its main component, which is a white to off white and slightly yellow solid powder soluble in water. Chantix is a tablet meant for oral administration which is supplied in 0.5 mg and 1 mg capsular biconvex. The 0.5 mg tablet has CHX 0.5 written on one side and Pfizer on the other and is white to off white in color, while the 1 mg tablet has CHX 1.0 on one side and Pfizer on the other and has a light blue color